16 results on '"Ramsey, David"'
Search Results
2. Risk Factors for Barrett’s Esophagus Compared Between African Americans and Non-Hispanic Whites
3. Corrigendum: Barrett's Esophagus Suspected at Endoscopy but No Specialized Intestinal Metaplasia on Biopsy, What's Next?
4. Barrett's Esophagus Suspected at Endoscopy but No Specialized Intestinal Metaplasia on Biopsy, What's Next?
5. Oral Bisphosphonates and the Risk of Barrettʼs Esophagus: Case–Control Analysis of US Veterans
6. Occupational History and the Risk of Barrettʼs Esophagus
7. Probiotic Bifidobacterium longum subsp. infantis 35624 in a Non-patient Population with a History of Abdominal Discomfort and Bloating
8. Psyllium Improves Glycemic Control in Patients with Type II Diabetes
9. Medications Altering Sex Hormone Balance and Risk of Advanced Liver Disease in HCV-infected Males
10. Rapid Symptom Resolution with Delayed-Release Mesalamine 4.8g/d Compared to 2.4g/d in Moderately Active Ulcerative Colitis Patients with a History of More Difficult to Treat Disease
11. Once Daily Dosing of Delayed-Release Oral Mesalamine (400 mg Tablet) is as Effective as Twice Daily Dosing for Maintenance of Remission of Ulcerative Colitis: Results of the QDIEM Study
12. Increased Efficacy of Delayed-Release mesalamine 4.8 g/D (800 mg Tablet) Compared to 2.4 g/D (400 mg Tablet) for Treatment of Moderately Active Ulcerative Colitis in Patients with a History of More Difficult to Treat Disease
13. Early and Sustained Efficacy of Delayed-Release Oral mesalamine in Moderately Active Ulcerative Colitis Patients
14. Previous History of Steroid Use Does Not Preclude Treatment with Mesalamine in Ulcerative Colitis (UC)
15. Rapid Symptom Resolution with Delayed Release Mesalamine in Mildly and Moderately Active UC
16. Endoscopically Measured Mucosal Healing Correlated with Response to Therapy in Moderately Active UC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.